Contract HHSO10033003T
Medimmune Llc · Department Of Health And Human Services · May 22, 2009
Medimmune Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on May 22, 2009 for $1.03 billion of work in biological product (except diagnostic) manufacturing. Performance is in Gaithersburg, MD. This is a task or delivery order issued under parent IDIQ HHSO100201200012I. The contract has been modified 199 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 21, 2024.
Contract details
- PIID
- HHSO10033003T
- Parent IDIQ
- HHSO100201200012I
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Gaithersburg, MD
- First action
- May 22, 2009
- Latest action
- June 21, 2024
Description
CLOSE THE TASK ORDER IN LINE WITH FAR 4.804
Modification timeline
-
June 21, 2024Mod P00004$0
-
June 21, 2024Mod P00001CLOSE CONTRACT IN LINE WITH FAR 4.804$0
-
April 12, 2024Mod P00004TO CLOSE THIS EXPIRED TASK ORDER, AND REASSIGN CONTRACTING OFFICER TO GILLIAN DAVID.$0
-
April 12, 2024Mod P00001CLOSEOUT OF EXPIRED TASK ORDER.$0
-
April 9, 2024Mod P00001UPDATE CONTRACTING OFFICER, CLOSEOUT CONTRACT PER FAR 4.804$0
-
April 5, 2024Mod P00001TASK ORDER #3- ACQUIRE ANCILLARY MATERIALS TO SUPPORT INFLUENZA PANDEMIC.$0
-
March 5, 2024Mod P00001BATTELLE MEMORIAL INSTITUTE BIO-AMT-1003 NATURAL HISTORY OF THE FERRET MODEL OF ZAIRE EBOLAVIRUS$-1.75M
-
August 17, 2023Mod P00012EVALUATION OF COAGULATION PATHWAY-TARGETING DRUGS IN THE RABBIT MODEL OF ACUTE RADIATION SYNDROME (ARS) FOR POTENTIAL NEW INDICATIONS AS ARS MEDICAL COUNTERMEAS$0
-
August 15, 2023Mod P00003DEOBLIGATION OF EXCESS FUNDS.$-8.1K
-
August 8, 2023Mod P00011EVALUATION OF COAGULATION PATHWAY-TARGETING DRUGS IN THE RABBIT MODEL OF ACUTE RADIATION SYNDROME (ARS) FOR POTENTIAL NEW INDICATIONS AS ARS MEDICAL COUNTERMEAS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO10033003T?
Contract HHSO10033003T is a federal contract awarded to Medimmune Llc by Department Of Health And Human Services on May 22, 2009 for $1.03 billion of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 199 times since the base award.
Who won contract HHSO10033003T?
Medimmune Llc won contract HHSO10033003T from Department Of Health And Human Services.
How much is contract HHSO10033003T worth?
Contract HHSO10033003T has obligated $1.03 billion to date.